Mission

Zeta Therapeutics is dedicated to the development of new and improved treatments for cancer using its unique nanotechnology platform.

Our first target is Ovarian Cancer, which is the leading cause of death from gynaecological cancers in Australia. Despite decades of intense research, still less than half of all women diagnosed with ovarian cancer will still be alive 5 years later. At Zeta Therapeutics we believe our technology can overcome one of the major barriers to improved treatment outcomes in this terrible disease.